Al-Qahtani, M. H., Jafri, M. A., Assidi, M., Buhmeida, A., Pushparaj, P. N., Abdullah, M. K., Alganmi, N. A. (2026). Multitargeted comparative evaluation suggests 2-Aoeobenoxmide shows favourable in silico binding compared to Tucatinib against ERα, HER2, AKT1, EGFR, and PIK3CA in breast cancer. Scientific Reports. https://doi.org/10.1038/s41598-026-57604-0